title: Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.
abstract: The presence of carcinoma in situ (CIS) lesions in the urinary bladder is associated with a high risk of disease progression to a muscle invasive stage. In this study, we used microarray expression profiling to examine the gene expression patterns in superficial transitional cell carcinoma (sTCC) with surrounding CIS (13 patients), without surrounding CIS lesions (15 patients), and in muscle invasive carcinomas (mTCC; 13 patients). Hierarchical cluster analysis separated the sTCC samples according to the presence or absence of CIS in the surrounding urothelium. We identified a few gene clusters that contained genes with similar expression levels in transitional cell carcinoma (TCC) with surrounding CIS and invasive TCC. However, no close relationship between TCC with adjacent CIS and invasive TCC was observed using hierarchical cluster analysis. Expression profiling of a series of biopsies from normal urothelium and urothelium with CIS lesions from the same urinary bladder revealed that the gene expression found in sTCC with surrounding CIS is found also in CIS biopsies as well as in histologically normal samples adjacent to the CIS lesions. Furthermore, we also identified similar gene expression changes in mTCC samples. We used a supervised learning approach to build a 16-gene molecular CIS classifier. The classifier was able to classify sTCC samples according to the presence or absence of surrounding CIS with a high accuracy. This study demonstrates that a CIS gene expression signature is present not only in CIS biopsies but also in sTCC, mTCC, and, remarkably, in histologically normal urothelium from bladders with CIS. Identification of this expression signature could provide guidance for the selection of therapy and follow-up regimen in patients with early stage bladder cancer.
authors.affiliation: Department of Clinical Biochemistry, Aarhus University Hospital, Skejby, Aarhus N, Denmark.
authors.forename: Lars
authors.initials: L
authors.lastname: Dyrskjøt
authors.forename: Mogens
authors.initials: M
authors.lastname: Kruhøffer
authors.forename: Thomas
authors.initials: T
authors.lastname: Thykjaer
authors.forename: Niels
authors.initials: N
authors.lastname: Marcussen
authors.forename: Jens L
authors.initials: JL
authors.lastname: Jensen
authors.forename: Klaus
authors.initials: K
authors.lastname: Møller
authors.forename: Torben F
authors.initials: TF
authors.lastname: Ørntoft
mesh_terms: D001706:Biopsy; D002278:Carcinoma in Situ / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*; D002295:Carcinoma, Transitional Cell / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D016000:Cluster Analysis; D020869:Gene Expression Profiling; D006801:Humans; D009367:Neoplasm Staging; D020411:Oligonucleotide Array Sequence Analysis; D001749:Urinary Bladder Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*